This trial is studying whether a tunneled pleural catheter (TPC) can improve quality of life for people with congestive heart failure (CHF) who have recurrent symptomatic pleural effusions that are not helped by diuretics.
2 Primary · 11 Secondary · Reporting Duration: 1 year post-enrollment
210 Total Participants · 2 Treatment Groups
Primary Treatment: tunneled pleural catheter · No Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: